Black Diamond Therapeutics, Inc. (BDTX)

NASDAQ: BDTX · IEX Real-Time Price · USD

5.75

-0.03 (-0.52%)

At close: Jul 19, 2024, 4:00 PM

5.67

-0.08 (-1.39%)

Pre-market: Jul 20, 2024, 9:27 AM EDT

BDTX Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	323	145	65	193	1,154
Market Cap Growth	280.29%	121.66%	-66.10%	-83.26%	-
Enterprise Value	229	35	-33	10	845
PE Ratio	-	-1.76	-0.72	-1.54	-17.15
PB Ratio	3.10	1.24	0.57	0.99	3.75
P/FCF Ratio	-3.87	-2.18	-0.77	-1.88	-22.06
P/OCF Ratio	-3.86	-2.17	-0.77	-1.93	-22.12
EV/EBITDA Ratio	-2.11	-0.43	0.37	-0.08	-12.58
EV/EBIT Ratio	-2.10	-0.43	0.36	-0.08	-12.57
EV/FCF Ratio	-2.47	-0.53	0.39	-0.10	-16.16
Debt / Equity Ratio	0.20	0.19	0.22	0.14	0.03
Debt / EBITDA Ratio	-0.27	-0.27	-0.28	-0.22	-0.11
Debt / FCF Ratio	-0.31	-0.33	-0.30	-0.27	-0.15
Quick Ratio	6.88	6.73	8.12	8.93	22.25
Current Ratio	7.05	6.82	8.37	9.12	22.48
Interest Coverage	-	-	-	-	-67253.00
Return on Equity (ROE)	-72.90%	-76.40%	-63.50%	-53.10%	-20.20%
Return on Assets (ROA)	-53.80%	-56.20%	-48.30%	-44.70%	-19.40%
Return on Capital (ROIC)	-67.75%	-62.24%	-65.84%	-56.63%	-22.05%
Earnings Yield	-24.67%	-56.82%	-139.28%	-65.04%	-5.83%
FCF Yield	-20.97%	-45.94%	-130.26%	-53.27%	-4.53%
Buyback Yield / Dilution	-42.00%	-21.00%	-0.38%	-9.97%	-1485.31%
Total Shareholder Return	-42.00%	-21.00%	-0.38%	-9.97%	-1485.31%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).